New York S03485 amends the insurance law to require prescription drug formulary coverage for interchangeable biologics and biosimilars.

New York S03485 amends the insurance law to require prescription drug formulary coverage for interchangeable biologics and biosimilars. It modifies existing sections to ensure that insurers and corporations with prescription drug formularies must cover biosimilars and interchangeable biologics. The bill also allows insurers to require patients to try a biosimilar or interchangeable biologic before covering the brand name prescription drug. This change aims to promote the use of cost-effective alternatives in prescription drug coverage.

New York S03485 amends the insurance law to require prescription drug formulary coverage for interchangeable biologics and biosimilars.

New York S03485 amends the insurance law to require prescription drug formulary coverage for interchangeable biologics and biosimilars. It modifies existing sections to ensure that insurers and corporations with prescription drug formularies must cover biosimilars and interchangeable biologics. The bill also allows insurers to require patients to try a biosimilar or interchangeable biologic before covering the brand name prescription drug. This change aims to promote the use of cost-effective alternatives in prescription drug coverage.